Home › Therapeutic areas › Blood products
Japan market screening · Therapeutic class
血液製剤類 · Japan Standard Commodity Classification
26 molecules in this class are marketed in Japan across 112 products. 9 of those products are not shipping normally today — 8.0% of the class. Supply status is reported to the Ministry of Health, Labour and Welfare and updated daily.
Ordered by how many products compete. Constrained means limited supply or supply suspended; supply suspended does not mean discontinued.
| Molecule | Products | Companies | Constrained | Supply mix |
|---|---|---|---|---|
| Polyethylene glycol treated human normal immunoglobulinポリエチレングリコール処理人免疫グロブリン | 9 | 2 | 6 | |
| Efraloctocog Alfa (Genetical Recombination)エフラロクトコグ アルファ（遺伝子組換え） | 8 | 1 | — | |
| Simoctocog Alfa (Genetical Recombination)シモクトコグ アルファ（遺伝子組換え） | 7 | 1 | — | |
| Efanesoctocog Alfa (Genetical Recombination)エフアネソクトコグ アルファ（遺伝子組換え） | 6 | 1 | — | |
| Eftrenonacog Alfa (Genetical Recombination)エフトレノナコグ アルファ（遺伝子組換え） | 6 | 1 | — | |
| Emicizumab (Genetical Recombination)エミシズマブ（遺伝子組換え） | 6 | 1 | — | |
| Lonoctocog Alfa (Genetical Recombination)ロノクトコグ アルファ（遺伝子組換え） | 6 | 1 | — | |
| Rurioctocog Alfa (Genetical Recombination)ルリオクトコグアルファ（遺伝子組換え） | 6 | 1 | — | |
| Rurioctocog Alfa Pegol (Genetical Recombination)ルリオクトコグ アルファ ペゴル（遺伝子組換え） | 6 | 1 | — | |
| Turoctocog Alfa (Genetical Recombination)ツロクトコグ アルファ（遺伝子組換え） | 6 | 1 | — | |
| Albutrepenonacog Alfa (Genetical Recombination)アルブトレペノナコグ アルファ（遺伝子組換え） | 5 | 1 | — | |
| Octocog Beta (Genetical Recombination)オクトコグ ベータ（遺伝子組換え） | 5 | 1 | — | |
| Turoctocog Alfa Pegol (Genetical Recombination)ツロクトコグ アルファ ペゴル（遺伝子組換え） | 5 | 1 | — | |
| Damoctocog Alfa Pegol (Genetical Recombination)ダモクトコグ アルファ ペゴル（遺伝子組換え） | 4 | 1 | — | |
| Human Normal Immunoglobulin人免疫グロブリン | 4 | 2 | — | |
| Nonacog Alfa (Genetical Recombination)ノナコグアルファ（遺伝子組換え） | 4 | 1 | — | |
| Whole Human Blood人全血液 | 4 | 1 | — | |
| Eptacog Alfa (Activated) (Genetical Recombination)エプタコグアルファ（活性型）（遺伝子組換え） | 3 | 1 | — | |
| Nonacog Beta Pegol (Genetical Recombination)ノナコグ ベータ ペゴル（遺伝子組換え） | 3 | 1 | 3 | |
| Antithrombin Gamma (Genetical Recombination)アンチトロンビン ガンマ（遺伝子組換え） | 2 | 1 | — | |
| Concizumab (Genetical Recombination)コンシズマブ（遺伝子組換え） | 2 | 1 | — | |
| Catridecacog (Genetical Recombination)カトリデカコグ（遺伝子組換え） | 1 | 1 | — | |
| Heminヘミン | 1 | 1 | — | |
| Marstacimab (Genetical Recombination)マルスタシマブ（遺伝子組換え） | 1 | 1 | — | |
| Susoctocog Alfa (Genetical Recombination)スソクトコグ アルファ（遺伝子組換え） | 1 | 1 | — | |
| Vonicog Alfa (Genetical Recombination)ボニコグ アルファ（遺伝子組換え） | 1 | 1 | — |
Products counts every marketed product across all strengths and forms, not companies. Companies is the number of companies marketing that molecule; the same company may appear under several molecules, so the column does not add up to a class total. Market size sits on each molecule's own page, valued at national price rather than transaction price. Figures are as at 2026-08-28.
Tell us which molecules matter to you. We will tell you what the public data can and cannot answer before you commission anything.
Send an enquiryOur Database Division replies in English within three business days (Japan time).